search
Back to results

A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women: IMARA SA (IMARA-SA pilot)

Primary Purpose

Sexually Transmitted Infection, Hiv

Status
Completed
Phase
Not Applicable
Locations
South Africa
Study Type
Interventional
Intervention
IMARA-SA (intervention group)
Health promotion control group
Sponsored by
University of Illinois at Chicago
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Sexually Transmitted Infection focused on measuring HIV prevention, Adolescent girls and young women, South Africa, Mother-daughter intervention

Eligibility Criteria

15 Years - 19 Years (Child, Adult)FemaleAccepts Healthy Volunteers

Inclusion criteria for AGYW include:

  1. Black or mixed race;
  2. 15-19 years-old;
  3. residing in Klipfontein/Mitchells Plain (K/MP);
  4. speak isiXhosa or English or a combination of these languages.

Inclusion criteria for FC include:

  1. identified by AGYW as a FC;
  2. 24 years and older;
  3. living with or in daily contact with the AGYW;
  4. speak isiXhosa or English or a combination of these languages.

Exclusion Criteria:

AGYW will be excluded from the study if they do not have a FC to participate in the study.

AGYW and FC will be excluded from the study if they:

  1. are unable to understand the consent/assent process and provide written informed consent;
  2. are currently enrolled in another research study addressing HIV/STIs/PrEP;
  3. participated in the IMARA-SA adaptation process. AGYW and FC must agree to participate as a dyad. AGYW refusal will supersede FC consent.

Sites / Locations

  • Desmond Tutu HIV Centre

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

IMARA-SA intervention arm

Health promotion control arm

Arm Description

Participants randomized to the IMARA-SA arm will receive the IMARA-SA intervention (i.e., the intervention group).

Participants randomized to the health promotion control arm will receive the health promotion intervention (i.e., the control group).

Outcomes

Primary Outcome Measures

Proportion of adolescent girls and young women (AGYW) with a sexually transmitted infection (STI) at baseline and follow-up
A positive test for at least one of two STIs: chlamydia and/or gonorrhea
Proportion of AGYW who complete HIV testing and counseling (HTC) at baseline and follow-up
Completion of HTC
Proportion of AGYW who elect to take pre-exposure prophylaxis (PrEP) at baseline and follow-up
Uptake of PrEP

Secondary Outcome Measures

Proportion of AGYW who report risky sexual behavior at baseline and follow-up
Sexual behavior (e.g., condom use, substance use during sex, number of partners, concurrent partners) will be measured via self-report using the AIDS Risk Behavior Assessment (ARBA) (Donenberg, 2001)
Proportion of AGYW who report adherence to PrEP at baseline and follow-up
Adherence to PrEP (where appropriate) will be measured via self-report using items from the Wilson scale (2017)

Full Information

First Posted
August 15, 2022
Last Updated
August 16, 2022
Sponsor
University of Illinois at Chicago
Collaborators
Desmond Tutu HIV Centre, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
search

1. Study Identification

Unique Protocol Identification Number
NCT05504954
Brief Title
A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women: IMARA SA
Acronym
IMARA-SA pilot
Official Title
Multilevel Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
October 26, 2019 (Actual)
Primary Completion Date
May 15, 2021 (Actual)
Study Completion Date
May 15, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Illinois at Chicago
Collaborators
Desmond Tutu HIV Centre, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Programs which go beyond individual-level behavior change to reduce HIV and STI infections among adolescent girls and young women in sub-Saharan Africa are essential to meet global HIV targets. Informed, Motivated, Aware and Responsible Adolescents and Adults- South Africa (IMARA-SA) is an evidence-based HIV-prevention intervention for adolescent girls and young women (AGYW) and their female caregivers, which has been adapted for a South African audience. This pilot study will assess feasibility in preparation for a randomized controlled trial (RCT). Additionally, the pilot will examine the preliminary effectiveness of IMARA-SA in reducing sexually transmitted infections (STI) and increasing uptake of HIV testing and counseling (HTC) and pre-exposure prophylaxis (PrEP) at follow-up among AGYW. About 60 AGYW-FC dyads will be enrolled and randomized to IMARA-SA or a health-promotion control arm. Following randomization, the dyads will participate in an ~2-day group workshop (~10 hours), which includes joint and separate mother and daughter activities. AGYW and FC will complete baseline assessments and follow-up assessments approximately 6 months later. Assessments will include surveys, STIs testing (for chlamydia and gonorrhea), and uptake of HTC and a 1-month PrEP prescription. Additionally, the intervention's implementation (e.g., acceptability) will be explored.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sexually Transmitted Infection, Hiv
Keywords
HIV prevention, Adolescent girls and young women, South Africa, Mother-daughter intervention

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Adolescent girl and young women-female caregiver (AGYW-FC) dyads will be randomized to the IMARA-SA intervention arm or a health promotion control arm matched in time and intensity. IMARA-SA and the health promotion program will be delivered as group interventions.
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
120 (Actual)

8. Arms, Groups, and Interventions

Arm Title
IMARA-SA intervention arm
Arm Type
Experimental
Arm Description
Participants randomized to the IMARA-SA arm will receive the IMARA-SA intervention (i.e., the intervention group).
Arm Title
Health promotion control arm
Arm Type
Experimental
Arm Description
Participants randomized to the health promotion control arm will receive the health promotion intervention (i.e., the control group).
Intervention Type
Behavioral
Intervention Name(s)
IMARA-SA (intervention group)
Intervention Description
The IMARA-SA intervention aligns with an ecological framework, emphasizing the intersection of individual, social, and structural determinants of women's sexual health and behavior. Separate FC and AGYW groups run simultaneously and cover parallel content, while joint activities enhance FC credibility as a resource for HIV/STI prevention and facilitate practice of communication skills. Interventionists use interactive and experiential activities. IMARA-SA's goals and motto emphasize strong FC-AGYW relationships, sisterhood, community empowerment, and motivation for HIV prevention, and build group cohesion. FC and AGYW sign a pact to confirm commitment to the program. At the end of Workshop Day 1, participants receive homework to complete during the week. Woven throughout IMARA-SA is the impact of mental health issues, alcohol and drug use, and violence on HIV-risk.
Intervention Type
Behavioral
Intervention Name(s)
Health promotion control group
Intervention Description
The health promotion control intervention is a family-based intervention previously delivered to families in SA and translated into isiXhosa. The intervention promotes healthy living by encouraging good nutrition, exercise, and violence reduction. It will be delivered in the same format as IMARA and will be identical in length and intensity.
Primary Outcome Measure Information:
Title
Proportion of adolescent girls and young women (AGYW) with a sexually transmitted infection (STI) at baseline and follow-up
Description
A positive test for at least one of two STIs: chlamydia and/or gonorrhea
Time Frame
~6 months (from baseline to follow-up)
Title
Proportion of AGYW who complete HIV testing and counseling (HTC) at baseline and follow-up
Description
Completion of HTC
Time Frame
~6 months (from baseline to follow-up)
Title
Proportion of AGYW who elect to take pre-exposure prophylaxis (PrEP) at baseline and follow-up
Description
Uptake of PrEP
Time Frame
~6 months (from baseline to follow-up)
Secondary Outcome Measure Information:
Title
Proportion of AGYW who report risky sexual behavior at baseline and follow-up
Description
Sexual behavior (e.g., condom use, substance use during sex, number of partners, concurrent partners) will be measured via self-report using the AIDS Risk Behavior Assessment (ARBA) (Donenberg, 2001)
Time Frame
~6 months (from baseline to follow-up)
Title
Proportion of AGYW who report adherence to PrEP at baseline and follow-up
Description
Adherence to PrEP (where appropriate) will be measured via self-report using items from the Wilson scale (2017)
Time Frame
~6 months (from baseline to follow-up)
Other Pre-specified Outcome Measures:
Title
Intervention reach
Description
Reach will be assessed as the proportion of AGYW who consented/assented to participate in the study.
Time Frame
~6 months (from baseline to follow-up)
Title
Intervention feasibility
Description
Feasibility will be measured as the proportion of AGYW in the IMARA-SA group who attend at least one session and receive the full 10-hour intervention.
Time Frame
~6 months (from baseline to follow-up)
Title
Intervention acceptability
Description
Acceptability will be measured through survey items completed by AGYW in the IMARA-SA group (e.g., satisfaction with the intervention day, perceptions of their facilitators, etc.).
Time Frame
~6 months (from baseline to follow-up)
Title
Intervention fidelity
Description
Fidelity will be assessed by observers of the intervention using an adapted version of the Treatment Fidelity Questionnaire (Lane et al, 2004).
Time Frame
~6 months (from baseline to follow-up)

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Participants will be eligible to participate if they are female.
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria for AGYW include: Black or mixed race; 15-19 years-old; residing in Klipfontein/Mitchells Plain (K/MP); speak isiXhosa or English or a combination of these languages. Inclusion criteria for FC include: identified by AGYW as a FC; 24 years and older; living with or in daily contact with the AGYW; speak isiXhosa or English or a combination of these languages. Exclusion Criteria: AGYW will be excluded from the study if they do not have a FC to participate in the study. AGYW and FC will be excluded from the study if they: are unable to understand the consent/assent process and provide written informed consent; are currently enrolled in another research study addressing HIV/STIs/PrEP; participated in the IMARA-SA adaptation process. AGYW and FC must agree to participate as a dyad. AGYW refusal will supersede FC consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Geri R Donenberg, PhD
Organizational Affiliation
University of Illinois Chicago
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Linda-Gail Bekker, MBChB, PhD
Organizational Affiliation
Desmond Tutu HIV Centre
Official's Role
Principal Investigator
Facility Information:
Facility Name
Desmond Tutu HIV Centre
City
Cape Town
State/Province
Western Cape
ZIP/Postal Code
7925
Country
South Africa

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Data will be available on request, pending discussion with the study team about the planned use of the data.
IPD Sharing Time Frame
Following all study publications

Learn more about this trial

A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women: IMARA SA

We'll reach out to this number within 24 hrs